Microenvironment drives cell state, plasticity, and drug response in pancreatic cancerSrivatsan Raghavan, Alex K. Shalek, Peter Winter et al.|Cell|2021Cited by 586
Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic CancerJulien Dilly, Brian M. Wolpin, Andrew J. Aguirre et al.|Cancer Discovery|2024Cited by 234
Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancerXinyuan Tong, Hongbin Ji, Ayushi S. Patel et al.|Cancer Cell|2024Cited by 115
Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic CancerHarshabad Singh, Andrew J. Aguirre, Valentina Nardi et al.|Clinical Cancer Research|2023Cited by 46
Comprehensive structure-function analysis reveals gain- and loss-of-function mechanisms impacting oncogenic KRAS activityJason J. Kwon, Andrew J. Aguirre, Julien Dilly et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 9